Acute Management of Sepsis beyond 24 Hours
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Sepsis manifests as a dysregulated immune response to an infection, leading to tissue damage, organ failure, and potentially death or long-term health issues. Sepsis remains a major health challenge globally, causing approximately 50 million cases and 11 million deaths annually. Early management of sepsis focuses on source control, antimicrobial treatment, and supporting vital organ function. Subsequent care includes metabolic, nutritional, and immune therapies to address the complex needs of septic patients. Metabolic management is based on obtaining moderate glucose targets. Nutritional support aims to mitigate hypercatabolism and muscle wasting, but aggressive early nutrition does not improve outcomes and could even be harmful. Immune modulation is crucial due to the dual nature of sepsis-induced immune responses. Corticosteroids have shown benefits in shock and organ dysfunction reversal and in mortality reduction with current guidelines recommending them in vasopressor therapy-dependent patients. In conclusion, sepsis management beyond the initial hours requires a multifaceted approach, focusing on metabolic, nutritional, and immune system support tailored to individual patient needs to enhance survival and recovery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A main feature of septic shock is the systemic vasodilation and capillary leak that lead to hypotension [4▪], requiring vasopressors that shunt blood away from the splanchnic circulation [5,6].”
From Gastrointestinal function and nutritional interventions in septic shock (2025) · cites this paper as [6]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196 · cited 1×
“An excessive proin fl ammatory response, i.e., the cytokine storm, 31 may lead to direct tissue damage, organ dysfunction, and ultimately death, whereas an excessive anti-in fl ammatory response may lead to insuf fi cient pathogen clearance.”
BackgroundSepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772 · cited 1×
“Sepsis-induced immunoparalysis, 50 a profound state of immunosuppression accounting for vulnerability to secondary infections and reactivation of latent infections, responsible for considerable late morbidity and mortality, has led to interest in immune-stimulating treatments.”
BackgroundHydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132 · cited 1×
“32,33 A meta-analysis of individual data from patients included in 17 randomized trials evaluating corticosteroid therapy in septic shock showed that the combination of hydrocortisone plus fl u-drocortisone was associated with a survival bene fi t (RR: 0.86; 95% CI: 0.79 – 0.92), whereas…”
MethodInfluentialInterleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., Marconi, V. C., Ruiz-Palacios, G. M., Hsieh, L., Kline, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031994 · Cited by 1,835
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696 · cited 1×
“23 Similar results were found in the pediatric ICU.”
ResultDerivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
Seymour, C. W., Kennedy, J. N., Wang, S., Chang, C.-C. H., Elliott, C. F., Xu, Z., Berry, S., Clermont, G., Cooper, G., Gomez, H., et al. (2019) · JAMA · doi:10.1001/jama.2019.5791 · Cited by 1,567
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Stone, J. H., Frigault, M. J., Serling-Boyd, N. J., Fernandes, A. D., Harvey, L., Foulkes, A. S., Horick, N. K., Healy, B. C., Shah, R., Bensaci, A. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2028836 · Cited by 1,362
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Salama, C., Han, J., Yau, L., Reiss, W. G., Kramer, B., Neidhart, J. D., Criner, G. J., Kaplan-Lewis, E., Baden, R., Pandit, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030340 · Cited by 1,291
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Rosas, I. O., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D., Aziz, M. S., Cooper, N., Douglas, I. S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028700 · Cited by 1,125
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
Hydrocortisone plus fludrocortisone for adults with septic shock.
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705716 · Cited by 939
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212722 · Cited by 904
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
Davenport, E. E., Burnham, K. L., Radhakrishnan, J., Humburg, P., Hutton, P., Mills, T. C., Rautanen, A., Gordon, A. C., Garrard, C., Hill, A. V. S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00046-1 · Cited by 856
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J.-C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.011 · Cited by 793
Timing of renal-replacement therapy in patients with acute kidney injury and sepsis.
Barbar, S. D., Clere-Jehl, R., Bourredjem, A., Hernu, R., Montini, F., Bruyère, R., Lebert, C., Bohé, J., Badie, J., Eraldi, J.-P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803213 · Cited by 777
Timing of initiation of renal-replacement therapy in acute kidney injury.
The STARRT-AKI Investigators (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2000741 · Cited by 771
Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.6820 · Cited by 734
Scicluna, B. P., van Vught, L. A., Zwinderman, A. H., Wiewel, M. A., Davenport, E. E., Burnham, K. L., Nürnberg, P., Schultz, M. J., Horn, J., Cremer, O. L., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30294-1 · Cited by 672
Permissive underfeeding or standard enteral feeding in critically ill adults
Arabi, Y. M., Aldawood, A. S., Haddad, S. H., Al-Dorzi, H. M., Tamim, H. M., Jones, G., Mehta, S., McIntyre, L., Solaiman, O., Sakkijha, M. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502826 · Cited by 614
Reignier, J., Boisramé-Helms, J., Brisard, L., Lascarrou, J.-B., Ait Hssain, A., Anguel, N., Argaud, L., Asehnoune, K., Asfar, P., Bellec, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32146-3 · Cited by 595
Early versus late parenteral nutrition in critically ill children
Fivez, T., Kerklaan, D., Mesotten, D., Verbruggen, S., Wouters, P. J., Vanhorebeek, I., Debaveye, Y., Vlasselaers, D., Desmet, L., Casaer, M. P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514762 · Cited by 558 · cited 1×
“24 Arabi and colleagues demonstrated that restriction of calorie and protein intake (40 – 60% of calculated caloric requirements compared with standard feeding) was safe in the critically ill (RR day 90 mortality: 0.94; 95% CI: 0.76 – 1.16; p ¼ 0.58).”
BackgroundInfluentialAngstwurm, M. W. A., Engelmann, L., Zimmermann, T., Lehmann, C., Spes, C. H., Abel, P., Strauß, R., Meier-Hellmann, A., Insel, R., Radke, J., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000251124.83436.0e · Cited by 509
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Guimarães, P. O., Quirk, D., Furtado, R. H., Maia, L. N., Saraiva, J. F., Antunes, M. O., Kalil Filho, R., Junior, V. M., Soeiro, A. M., Tognon, A. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101643 · Cited by 435
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Francois, B., Jeannet, R., Daix, T., Walton, A. H., Shotwell, M. S., Unsinger, J., Monneret, G., Rimmelé, T., Blood, T., Morre, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98960 · Cited by 431 · cited 1×
“52,53 PD1 and PDL1 are implicated in T cell death, blocking their interaction modulating cytokine production, and reducing organ dysfunction and mortality in animal models of sepsis.”
BackgroundJaber, S., Paugam, C., Futier, E., Lefrant, J.-Y., Lasocki, S., Lescot, T., Pottecher, J., Demoule, A., Ferrandière, M., Asehnoune, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31080-8 · Cited by 410
Heyland, D. K., Patel, J., Compher, C., Rice, T. W., Bear, D. E., Lee, Z.-Y., González, V. C., O'Reilly, K., Regala, R., Wedemire, C., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02469-2 · Cited by 401
Antcliffe, D. B., Burnham, K. L., Al-Beidh, F., Santhakumaran, S., Brett, S. J., Hinds, C. J., Ashby, D., Knight, J. C., & Gordon, A. C. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1419oc · Cited by 365
Hermans, G., Casaer, M. P., Clerckx, B., Güiza, F., Vanhullebusch, T., Derde, S., Meersseman, P., Derese, I., Mesotten, D., Wouters, P. J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70183-8 · Cited by 364
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Lamontagne, F., Masse, M.-H., Menard, J., Sprague, S., Pinto, R., Heyland, D. K., Cook, D. J., Battista, M.-C., Day, A. G., Guyatt, G. H., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200644 · Cited by 350
Annane, D., Sébille, V., & Bellissant, E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194723.78632.62 · Cited by 328
Gaudry, S., Hajage, D., Martin-Lefevre, L., Lebbah, S., Louis, G., Moschietto, S., Titeca-Beauport, D., Combe, B. L., Pons, B., de Prost, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00350-0 · Cited by 288 · cited 1×
“17 The indications for RRT must remain limited to emergencies that are refractory to appropriate medical management such as severe hyperkalemia, severe metabolic acidosis, hydrostatic pulmonary edema, or persistent AKI marked by anuria or urea levels higher than 112mg/dL for over 3 days.”
BackgroundReignier, J., Plantefeve, G., Mira, J.-P., Argaud, L., Asfar, P., Aissaoui, N., Badie, J., Botoc, N.-V., Brisard, L., Bui, H.-N., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00092-9 · Cited by 270
Hotchkiss, R. S., Colston, E., Yende, S., Angus, D. C., Moldawer, L. L., Crouser, E. D., Martin, G. S., Coopersmith, C. M., Brakenridge, S., Mayr, F. B., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003685 · Cited by 252
Leentjens, J., Kox, M., Koch, R. M., Preijers, F., Joosten, L. A. B., van der Hoeven, J. G., Netea, M. G., & Pickkers, P. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0645oc · Cited by 244
Gaudry, S., Hajage, D., Benichou, N., Chaïbi, K., Barbar, S., Zarbock, A., Lumlertgul, N., Wald, R., Bagshaw, S. M., Srisawat, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30531-6 · Cited by 240
Hotchkiss, R. S., Colston, E., Yende, S., Crouser, E. D., Martin, G. S., Albertson, T., Bartz, R. R., Brakenridge, S. C., Delano, M. J., Park, P. K., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05704-z · Cited by 206
Honarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006174 · Cited by 202
IL-7 Restores Lymphocyte Functions in Septic Patients
Venet, F., Foray, A.-P., Villars-Méchin, A., Malcus, C., Poitevin-Later, F., Lepape, A., & Monneret, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202062 · Cited by 199 · cited 1×
“51 Recombinant IL-7 increased the circulating levels of lymphocytes in two small sepsis trials.”
BackgroundTight blood-glucose control without early parenteral nutrition in the ICU
Gunst, J., Debaveye, Y., Güiza, F., Dubois, J., De Bruyn, A., Dauwe, D., De Troy, E., Casaer, M. P., De Vlieger, G., Haghedooren, R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304855 · Cited by 163
High-dose selenium substitution in sepsis: a prospective randomized clinical trial
Valenta, J., Brodska, H. L., Drábek, T., Hendl, J., & Kazda, A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2153-0 · Cited by 155
Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
Leventogiannis, K., Kyriazopoulou, E., Antonakos, N., Kotsaki, A., Tsangaris, I., Markopoulou, D., Grondman, I., Rovina, N., Theodorou, V., Antoniadou, E., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100817 · Cited by 150
Aman, J., Duijvelaar, E., Botros, L., Kianzad, A., Schippers, J. R., Smeele, P. J., Azhang, S., Bartelink, I. H., Bayoumy, A. A., Bet, P. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00237-x · Cited by 121 · cited 1×
“49 Due to similarities in the pathophysiology of COVID-19 and sepsis, translating these fi ndings to bacterial sepsis is worth being considered.”
BackgroundGaudry, S., Grolleau, F., Barbar, S. D., Martin‐Lefèvre, L., Pons, B., Boulet, É., Boyer, A., Chevrel, G., Montini, F., Bohé, J., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03955-9 · Cited by 121
Daix, T., Mathonnet, A., Brakenridge, S. C., Dequin, P., Mira, J. P., Berbille, F., Morre, M., Jeannet, R., Blood, T. M., Unsinger, J., et al. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01109-w · Cited by 102 · cited 1×
“52,53 PD1 and PDL1 are implicated in T cell death, blocking their interaction modulating cytokine production, and reducing organ dysfunction and mortality in animal models of sepsis.”
BackgroundLee, Z., Dresen, E., Lew, C. C. H., Bels, J. L. M., Hill, A., Hasan, M. S., Ke, L., van Zanten, A. R. H., van de Poll, M. C. G., Heyland, D. K., et al. (2024) · Critical Care · doi:10.1186/s13054-023-04783-1 · Cited by 92
François, B., Lambden, S., Fivez, T., Gibot, S., Derive, M., Grouin, J., Salcedo‐Magguilli, M., Lemarie, J., Schryver, N. D., Jalkanen, V., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00158-3 · Cited by 88
Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock
Pirracchio, R., Annane, D., Waschka, A. K., Lamontagne, F., Arabi, Y. M., Bollaert, P., Billot, L., Du, B., Briegel, J., Cohen, J., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2300034 · Cited by 85 · cited 2×
“34,35 In sepsis, cortico-steroids reduce circulating levels of proin fl ammatory cytokines.”
BackgroundPinder, E. M., Rostron, A., Hellyer, T. P., Ruchaud‐Sparagano, M., Scott, J., Macfarlane, J., Wiscombe, S., Widdrington, J. D., Roy, A. I., Linnett, V. C., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-211323 · Cited by 83 · cited 1×
“56,57 TREM 1 is expressed on myeloid cells and promotes in fl ammation.”
BackgroundWald, R., Gaudry, S., da Costa, B. R., Adhikari, N. K. J., Bellomo, R., Du, B., Gallagher, M. P., Hoste, E. A., Lamontagne, F., Joannidis, M., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07211-8 · Cited by 82
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Verney, C., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1255oc · Cited by 80
Pirracchio, R., Hubbard, A., Sprung, C. L., Chevret, S., Annane, D., & Collaborators, R. R. O. C. R. O. S. S. (. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29050 · Cited by 75
Piton, G., Gouge, A. L., Helms, J., Anguel, N., Argaud, L., Asfar, P., Botoc, V., Bretagnol, A., Brisard, L., Bui, H.-N., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06637-w · Cited by 72
Kotsaki, A., Pickkers, P., Bauer, M. W., Calandra, T., Lupșe, M. S., Wiersinga, W. J., Meylan, S., Bloos, F., van der Poll, T., Slim, M. A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-067251 · Cited by 70
Parenteral Vitamin C in Patients with Severe Infection: A Systematic Review
Agarwal, A., Basmaji, J., Fernando, S. M., Ge, F. Z., Xiao, Y., Faisal, H., Honarmand, K., Hylands, M., Lau, V. I., Lewis, K. A., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200105 · Cited by 48
Randomized Phase 3 Trial of Ruxolitinib for COVID-19–Associated Acute Respiratory Distress Syndrome*
Rein, L. A. M., Calero, K., Shah, R., Ojielo, C. I., Hudock, K. M., Lodhi, S., Sadaka, F. G., Bellam, S. K., Palma, C., Hager, D. N., et al. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005682 · Cited by 43
The artificial kidney induces acute kidney injury: yes
Bénichou, N., Gaudry, S., & Dreyfuss, D. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05891-9 · Cited by 28
Fleuriet, J., Heming, N., Meziani, F., Reignier, J., Declercq, P.-L., Mercier, E., Müller, G., Colin, G., Monnet, X., Robine, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066496 · Cited by 28
Self-citationYanase, F., Spano, S., Maeda, A., Chaba, A., Naorungroj, T., Ow, C. P. C., Lankadeva, Y. R., May, C. N., Betrie, A. H., Lane, D. J. R., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04644-x · Cited by 27
Jung, B., Huguet, H., Molinari, N., & Jaber, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073487 · Cited by 20 · cited 1×
“16 A strategy for signi fi - cantly delaying the initiation of RRT in AKI patients with anuria lasting over 72hours or a urea level surpassing 112 mg/dL did not demonstrate any ef fi cacy in the AKIKI 2 trial and could potentially lead to harm.”
MethodAnnane, D., Pirracchio, R., Billot, L., Waschka, A. K., Chevret, S., Cohen, J., Finfer, S. R., Gordon, A. C., Hammond, N. E., Myburgh, J., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040931 · Cited by 6
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19
Cafardi, J. M., Miller, C. B., Terebelo, H. R., Tewell, C., Benzaquen, S., Park, D., Egan, P., Lebovic, D. J., Pettit, K. M., Whitman, E. D., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.42918 · Cited by 6
Adigbli, D. K., Li, Y., Hammond, N. E., Annane, D., Arabi, Y. M., Bilotta, F., Bohé, J., Brunkhorst, F. M., Cavalcanti, A. B., Cook, D., et al. (2023) · Critical Care Science · doi:10.5935/2965-2774.20230162-en · Cited by 5
Cited by
Gastrointestinal function and nutritional interventions in septic shock
Bachmann, K. F., Cotoia, A., & Reintam Blaser, A. (2025) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001302 · Cited by 13
Gut microbiota and sepsis: mechanisms, clinical correlations, and therapeutic prospects
Yu, J., & Liu, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1793041 · Cited by 4
“During septic shock, systemic vasodilation and capillary leakage (86) necessitate the use of vasopressor agents to elevate blood pressure, which subsequently reduces splanchnic blood flow and induces intestinal microcirculatory impairment (87, 88, 89).”
Metadata
- Authors
- Premachandra, A., & Heming, N.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Corresponding author
- Heming, Nicholas
- Venue
- Seminars in Respiratory and Critical Care Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2024-07-05
- Volume
- 45
- Issue
- 04
- Pages
- 510-515
- ISSN
- 1069-3424 (ISSN-L)
- 1098-9048
- OpenAlex
- W4400348392
- Cited by
- 2
- References
- 71
- Citations by year
- 2026: 1 · 2025: 1
- FWCI
- 0.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Keywords
- sepsis, metabolic control, glycemic targets, nutritional support, hypercatabolism, muscle atrophy, immunomodulation, corticosteroids, organ dysfunction, sepsis-induced immunosuppression
- MeSH terms
- Adrenal Cortex Hormones, Humans, Time Factors, Nutritional Support, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.